The immunization schedule protects against 14 potentially serious diseases before a child’s second birthday, as recommended ...

Hamilton families have one last chance to get their babies immunized against a common virus that can cause serious lung infections before a clinic at McMaster Children’s Hospital closes. The last ...

This isn't just another routine winter — we’re facing a perfect storm of respiratory threats that are showing tremendous ...

A cohort study found that nearly three fourths of infants received respiratory syncytial virus protection with either nirsevimab or through exposure to maternal RSVpreF in the 2023-2024 season.

The VDH reported on May 22 that a second juvenile in the "Under 10" age range has died of COVID-19 since the pandemic began ...

USA: Researchers have found in a new study that a respiratory syncytial virus (RSV) prevention strategy combining prenatal ...

When existing systems do not accommodate access to health care innovation, we must change those systems. Fulfilling nirsevimab’s promise will require overcoming entrenched hospital payment norms.

More than 2 years after the child was born, no identifiable features of SMA have been observed, reported Richard Finkel, MD, of St. Jude Children's Research Hospital in Memphis, Tennessee, and ...

A study today in JAMA Network Open from the University of California, San Francisco (UCSF), shows a high uptake of respiratory syncytial virus (RSV) vaccine and the RSV-preventing monoclonal antibody ...

High uptake of RSVpreF vaccine and nirsevimab was observed, with 64% of pregnant individuals and 70% of infants receiving ...

The medication, called nirsevimab, is given via injection to infants under eight months old and uses lab-made antibodies to ...

The medication – nirsevimab – is given via injection to infants under 8 months old. Unlike a vaccine, the immunization ...